Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?

Journal of Hepatology

Volumn 63, Issue 2, 2015, Pages 309-311

  Merli, Manuela ^a   Dasarathy, Srinivasan ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN RECEPTOR; INTERLEUKIN 6; LEPTIN; MYOSTATIN; TRANSFORMING GROWTH FACTOR BETA;

ADIPOSE TISSUE; AGING; BODY COMPOSITION; BODY MASS; BODY WEIGHT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; EDITORIAL; ENERGY EXPENDITURE; FAT MASS; FATTY ACID OXIDATION; HUMAN; METABOLIC SYNDROME X; MUSCLE MASS; MUSCLE METABOLISM; MUSCLE TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SARCOPENIA; SARCOPENIC OBESITY; SKELETAL MUSCLE; STELLATE CELL; COMPLICATION; FEMALE; INSULIN RESISTANCE; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

FEMALE; HUMANS; INSULIN RESISTANCE; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; SARCOPENIA;

EID: 84942823057     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.05.014     Document Type: Editorial

References (21)

1. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124-131.
2. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005;42:44-52.
3. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight Loss via Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology 2015. http://dx.doi.org/10.1053/j.gastro.2015.04.005, [Epub ahead of print].
4. Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology 2014;59:1772-1778.
5. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010;33: 1652-1654.
6. Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 2010;33:1497-1499.
7. Lee YH, Jung KS, Kim SU, Yoon HJ, Yun YJ, Lee BW, et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008-2011). J Hepatol 2015;63:486-493.
8. Kim SW, Jung HW. Which one is associated with nonalcoholic fatty liver disease? Small muscle mass or large fat mass. Hepatology 2015;61:1764.
9. Issa D, Alkhouri N, Tsien C, Shah S, Lopez R, McCullough A, et al. Presence of sarcopenia (muscle wasting) in patients with nonalcoholic steatohepatitis. Hepatology 2014;60:428-429.
10. Dasarathy J, Periyalwar P, Allampati S, Bhinder V, Hawkins C, Brandt P, et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int 2014;34: e118-e127.
11. Bredella MA, Ghomi RH, Thomas BJ, Torriani M, Brick DJ, Gerweck AV, et al. Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa. Obesity (Silver Spring) 2010;18:2227-2233.
12. Giusto M, Lattanzi B, Albanese C, Galtieri A, Farcomeni A, Giannelli V, et al. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry. Eur J Gastroenterol Hepatol 2015;27:328-334.
13. Henningsen J, Rigbolt KT, Blagoev B, Pedersen BK, Kratchmarova I. Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol Cell Proteomics 2010;9:2482-2496.
14. McPherron AC, Guo T, Bond ND, Gavrilova O. Increasing muscle mass to improve metabolism. Adipocyte 2013;2:92-98.
15. Dasarathy S. Is the adiponectin-AMPK-mitochondrial axis involved in progression of nonalcoholic fatty liver disease? Hepatology 2014;60: 22-25.
16. Bonala S, McFarlane C, Ang J, Lim R, Lee M, Chua H, et al. Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity. Mol Endocrinol 2013;27:1518-1535.
17. Zhang C, McFarlane C, Lokireddy S, Bonala S, Ge X, Masuda S, et al. Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway. Diabetologia 2011;54:1491-1501.
18. Dasarathy S, Muc S, Runkana A, Mullen KD, Kaminsky-Russ K, McCullough AJ. Alteration in body composition in the portacaval anastamosis rat is mediated by increased expression of myostatin. Am J Physiol Gastrointest Liver Physiol 2011;301:G731-G738.
19. Seldin MM, Peterson JM, Byerly MS, Wei Z, Wong GW. Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J Biol Chem 2012;287:11968-11980.
20. Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS. Irisin in patients with nonalcoholic fatty liver disease. Metabolism 2014;63: 207-217.
21. Glass C, Hipskind P, Tsien C, Malin SK, Kasumov T, Shah SN, et al. Sarcopenia and a physiologically low respiratory quotient in patients with cirrhosis: a prospective controlled study. J Appl Physiol 1985;2013:559-565.